125 related articles for article (PubMed ID: 38697036)
1. Antiplatelet Treatment in Moyamoya Disease: A Systematic Review.
Kijpaisalratana N; Ariyaprakai C; Sriamornrattanakul K; Wongsuriyanan S; Akharathammachote N; Susantitaphong P; Suwanwela NC
Cerebrovasc Dis Extra; 2024; 14(1):76-85. PubMed ID: 38697036
[TBL] [Abstract][Full Text] [Related]
2. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
[TBL] [Abstract][Full Text] [Related]
3. Cilostazol for the management of moyamoya disease: a systematic review of the early evidence, efficacy, safety, and future directions.
Abedi A; Sizdahkhani S; Choi W; Nguyen VN; Rennert RC; Russin JJ
Neurosurg Focus; 2023 Oct; 55(4):E9. PubMed ID: 37778042
[TBL] [Abstract][Full Text] [Related]
4. Ameliorative Effects of Combined Revascularization Surgery on Abnormal Collateral Channels in Moyamoya Disease.
Yamamoto S; Kashiwazaki D; Uchino H; Saito H; Hori E; Akioka N; Kuwayama N; Kuroda S
J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105624. PubMed ID: 33516067
[TBL] [Abstract][Full Text] [Related]
5. Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis.
Liu T; Qin M; Xiong X; Li T; Feng L; Lai X; Gao Y
Front Neurol; 2023; 14():1132339. PubMed ID: 37409015
[TBL] [Abstract][Full Text] [Related]
6. Intravenous thrombolysis and endovascular thrombectomy for acute ischaemic stroke in patients with Moyamoya disease - a systematic review and meta-summary of case reports.
Koh MY; Toh KZ; Ho JS; Yeo LL; Ho AF; Sia CH; Tan BY
J Thromb Thrombolysis; 2022 Aug; 54(2):339-349. PubMed ID: 35699873
[TBL] [Abstract][Full Text] [Related]
7. The natural clinical course of hemodynamically stable adult moyamoya disease.
Cho WS; Chung YS; Kim JE; Jeon JP; Son YJ; Bang JS; Kang HS; Sohn CH; Oh CW
J Neurosurg; 2015 Jan; 122(1):82-9. PubMed ID: 25361479
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet therapy may improve the prognosis of patients with moyamoya disease: a 12-year retrospective study.
Luo Y; Cao Z; Ye H; Wu S; Sun X
J Neurol; 2023 Aug; 270(8):3876-3884. PubMed ID: 37106259
[TBL] [Abstract][Full Text] [Related]
9. Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials.
Shao QY; Wang ZJ; Ma XT; Lin XZ; Pan L; Zhou YJ
BMC Cardiovasc Disord; 2021 Dec; 21(1):574. PubMed ID: 34852763
[TBL] [Abstract][Full Text] [Related]
10. Risk profile in extracranial/intracranial bypass surgery--the role of antiplatelet agents, disease pathology, and surgical technique in 168 direct revascularization procedures.
Schubert GA; Biermann P; Weiss C; Seiz M; Vajkoczy P; Schmiedek P; Thomé C
World Neurosurg; 2014 Nov; 82(5):672-7. PubMed ID: 23838364
[TBL] [Abstract][Full Text] [Related]
11. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
[TBL] [Abstract][Full Text] [Related]
12. Effects of Surgery and Antiplatelet Therapy in Ten-Year Follow-Up from the Registry Study of Research Committee on Moyamoya Disease in Japan.
Yamada S; Oki K; Itoh Y; Kuroda S; Houkin K; Tominaga T; Miyamoto S; Hashimoto N; Suzuki N;
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):340-9. PubMed ID: 26654669
[TBL] [Abstract][Full Text] [Related]
13. Postoperative Functional Outcomes and Prognostic Factors in Two Types of Adult Moyamoya Diseases.
Zhang M; Tang J; Liu N; Xue Y; Ren X; Fu J
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104846. PubMed ID: 32439351
[TBL] [Abstract][Full Text] [Related]
14. Natural course of hemodynamically stable hemispheres contralateral to operated hemispheres in adult patients with ischemic moyamoya diseases.
Kang YS; Cho WS; Nam SM; Chung Y; Lee SH; Kim K; Kang HS; Kim JE
Sci Rep; 2024 Apr; 14(1):8358. PubMed ID: 38600292
[TBL] [Abstract][Full Text] [Related]
15. Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study.
Seo WK; Kim JY; Choi EH; Kim YS; Chung JW; Saver JL; Bang OY; Kim GM
J Am Heart Assoc; 2021 Feb; 10(5):e017701. PubMed ID: 33615836
[TBL] [Abstract][Full Text] [Related]
16. Clinical course of asymptomatic adult moyamoya disease.
Jo KI; Yeon JY; Hong SC; Kim JS
Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Effects between Clopidogrel and Cilostazol on Cerebral Perfusion in Nonsurgical Adult Patients with Symptomatically Ischemic Moyamoya Disease: Subanalysis of a Prospective Cohort.
Chiba T; Setta K; Shimada Y; Yoshida J; Fujimoto K; Tsutsui S; Yoshida K; Kobayashi M; Kubo Y; Fujiwara S; Terasaki K; Ogasawara K
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3373-3379. PubMed ID: 30174225
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
19. Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass.
Jiang H; Ni W; Xu B; Lei Y; Tian Y; Xu F; Gu Y; Mao Y
J Neurosurg; 2014 Nov; 121(5):1048-55. PubMed ID: 25127415
[TBL] [Abstract][Full Text] [Related]
20. Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study.
Yoo J; Jeon J; Baik M; Kim J
Stroke Vasc Neurol; 2023 Aug; 8(4):276-283. PubMed ID: 36549762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
